VivoSim Labs (VIVS) Surges 19.8% After Clinical Trial Breakthrough
VivoSim Labs Inc. (NASDAQ:VIVS) is an emerging biotechnology company pioneering the next generation of non-animal, simulation-based testing solutions…
Browsing Tag